Literature DB >> 22986243

Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.

Christoph Schaudinn1, Amita Gorur, Paul Webster, Allan C Jones, Michael Neely, Roger W Jelliffe, Anh D Le, Parish P Sedghizadeh.   

Abstract

OBJECTIVE: Recently, specific in vitro bisphosphonate concentrations have been established for reaching a toxic threshold that could result in the induction of bisphosphonate-related osteonecrosis of the jaw (BRONJ), but these data have not been validated in vivo. The purpose of this study was to quantify the concentration of bisphosphonates (BPs) in the diseased jaw bone of patients experiencing BRONJ. STUDY
DESIGN: We hypothesized that if the average natural nitrogen content of mammalian bone is known, the excess of nitrogen in the jaw bone of BRONJ patients is likely to reflect the concentration of amino-BP. To test our hypothesis, jaw bone specimens from patients with BRONJ were acquired after sequestrectomy and analyzed by energy-dispersive X-ray spectroscopy (EDS).
RESULTS: The EDS analysis of the bone demonstrated a highly linear correlation between increasing concentrations of BP and the increasing percentage of nitrogen measured at the bone surfaces (R(2) = .9851, P = .0149).
CONCLUSIONS: SEM/EDS can be a valuable tool for assessing BP concentration in jaw bone and provides important insight into BP pharmacokinetics and BRONJ.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986243     DOI: 10.1016/j.oooo.2012.06.006

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  5 in total

1.  Population pharmacokinetic and pharmacodynamic modeling for assessing risk of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Parish P Sedghizadeh; Allan C Jones; Chris LaVallee; Roger W Jelliffe; Anh D Le; Peter Lee; Andrew Kiss; Michael Neely
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-12-12

Review 2.  Bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.

Authors:  Andrea Piccioli
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-14

3.  Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications.

Authors:  Parish P Sedghizadeh; Shuting Sun; Allan C Jones; Esmat Sodagar; Philip Cherian; Casey Chen; Adam F Junka; Jeffrey D Neighbors; Charles E McKenna; R Graham G Russell; Frank H Ebetino
Journal:  Bone       Date:  2021-03-20       Impact factor: 4.626

4.  Summary of the various treatments for osteonecrosis of the femoral head by mechanism: A review.

Authors:  Cheng Wang; Jiang Peng; Shibi Lu
Journal:  Exp Ther Med       Date:  2014-06-26       Impact factor: 2.447

5.  Copper accumulation in the sequestrum of medication-related osteonecrosis of the jaw.

Authors:  Tomoko Sugiyama; Motohiro Uo; Teruyasu Mizoguchi; Takahiro Wada; Daisuke Omagari; Kazuo Komiyama; Yoshiyuki Mori
Journal:  Bone Rep       Date:  2015-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.